These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15660048)

  • 61. Metoprolol: a review of its use in chronic heart failure.
    Prakash A; Markham A
    Drugs; 2000 Sep; 60(3):647-78. PubMed ID: 11030472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
    Koelling TM; Joseph S; Aaronson KD
    J Heart Lung Transplant; 2004 Dec; 23(12):1414-22. PubMed ID: 15607672
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience.
    Batisky DL; Sorof JM; Sugg J; Llewellyn M; Klibaner M; Hainer JW; Portman RJ; Falkner B;
    J Pediatr; 2007 Feb; 150(2):134-9, 139.e1. PubMed ID: 17236889
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.
    Roughead EE; Barratt JD; Ramsay E; Pratt N; Ryan P; Peck R; Killer G; Gilbert AL
    Circ Heart Fail; 2009 Sep; 2(5):424-8. PubMed ID: 19808372
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.
    Gustafsson I; Brendorp B; Seibaek M; Burchardt H; Hildebrandt P; Køber L; Torp-Pedersen C;
    J Am Coll Cardiol; 2004 Mar; 43(5):771-7. PubMed ID: 14998615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Population-based analysis of class effect of β blockers in heart failure.
    Lazarus DL; Jackevicius CA; Behlouli H; Johansen H; Pilote L
    Am J Cardiol; 2011 Apr; 107(8):1196-202. PubMed ID: 21349489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up.
    Ferrante D; Varini S; Macchia A; Soifer S; Badra R; Nul D; Grancelli H; Doval H;
    J Am Coll Cardiol; 2010 Jul; 56(5):372-8. PubMed ID: 20650358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure.
    Andersson C; Weeke P; Pecini R; Kjaergaard J; Hassager C; Køber L; Torp-Pedersen C
    Scand Cardiovasc J; 2010 Feb; 44(1):37-44. PubMed ID: 19878095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
    Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
    Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure].
    Di Lenarda A
    Ital Heart J Suppl; 2000 Aug; 1(8):1063-5. PubMed ID: 10993017
    [No Abstract]   [Full Text] [Related]  

  • 75. Metoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure.
    Hole T; Frøland G; Gullestad L; Offstad J; Skjaerpe T
    Echocardiography; 2004 Apr; 21(3):215-23. PubMed ID: 15053783
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
    Rydén L; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Packer M; Poole-Wilson PA
    Eur Heart J; 2000 Dec; 21(23):1967-78. PubMed ID: 11071803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tolerability of beta-blockers in heart failure: reassurance needed, reassurance provided.
    Krum H
    Ital Heart J; 2003 Apr; 4(4):225-7. PubMed ID: 12784773
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metoprolol CR/XL in the treatment of chronic heart failure.
    Gattis WA
    Pharmacotherapy; 2001 May; 21(5):604-13. PubMed ID: 11349749
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical studies on beta blockers and heart failure preceding the MERIT-HF Trial. Metoprolol CR/XL Randomized Intervention Trial in Heart Failure.
    Goldstein S
    Am J Cardiol; 1997 Nov; 80(9B):50J-53J. PubMed ID: 9375951
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.